why choose us

First received: January 09, 2025

Clinical Trial: A Study to Assess the Effect of Ceftobiprole on the PK of Pitavastatin and on Plasma Levels of Coproporphyrin

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Drug-drug Interaction Study

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Single-center, Open-label, Non-randomized, Fixed-sequence, Drug-drug Interaction Study to Assess the Effect of Repeated Doses of Intravenous Ceftobiprole on the Pharmacokinetics of Oral Pit

Brief Summary: The goal of this clinical study is to determine the effect of the test drug ceftobiprole (a drug approved for the treatment of bacterial infections) on the elimination of pitavastatin (a drug approved for the treatment of increased levels of cholesterol in blood) from the body.This interaction will be investigated by pharmacokinetic (PK) assessments.The PK of pitavastatin will be assessed when administered alone and when administered together with ceftobiprole in a study design including two treatment periods.The…

Read more